The Herbert Irving Comprehensive Cancer Center (HICCC) Shared Resource for Research Recruitmentand Minority Outreach (RRMO) provides recruitment and follow-up of human subjects in cancer researchand serves as an informational resource for the community about clinical trials and observational studies,with a special focus on historically underserved racial/ethnic minorities. Our specific objectives are: (1) toprovide recruitment and follow-up services to investigators; (2) to attract potential study participants to theCancer Center by working with community physicians, community organizations, and interested individuals;(3) to inform the community and medical caregivers, about state-of-the-art cancer treatment, prevention,and research results; (4) to respond to community cancer concerns and research needs; and (5) to provideour colleagues with the benefit of our experience by analyzing and reporting on our recruitment and followupresults. Services provided include: Recruiting, screening and consenting subjects into cancer clinical trials and observational studies Advertising available trials and recruiting patients into studies via the distribution of IRB-stampedrecruitment flyers and the RRMO newsletter. Identifying and addressing barriers to recruitment and retention associated with ongoing studies Use of the RRMO recruitment and outreach database. Communicating with potential subjects through mailings, special events, RRMO newsletter and website Inreach and outreach to provide education about clinical research with cultural and language-specificprograms and materials in English and Spanish.Since 2001, RRMO has recruited more than 4300 subjects to therapeutic trials, palliative care andsurvivorship initiatives, and epidemiologic, behavioral, and prevention and control studies. We haveenrolled close to 1000 subjects, including 19% of African or Hispanic descent, in clinical trials, mainly NCIorDOD-sponsored. In the next grant period, we hope to broaden the range of organ/site specialties inwhich we provide services to investigators.The projected operating budget for the RRMO SR is $417,528; this request is for $67,779 for salary andfringe benefits to support 69% effort of the project manager.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-35
Application #
7669930
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-08-01
Project End
2013-06-30
Budget Start
2008-08-01
Budget End
2009-06-30
Support Year
35
Fiscal Year
2008
Total Cost
$59,582
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Jauregui, Ruben; Thomas, Amanda L; Liechty, Benjamin et al. (2018) SCAPER-associated nonsyndromic autosomal recessive retinitis pigmentosa. Am J Med Genet A :
Ghorpade, Devram S; Ozcan, Lale; Zheng, Ze et al. (2018) Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature 555:673-677
Bianchetti, E; Bates, S J; Carroll, S L et al. (2018) Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors. Sci Rep 8:17390
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative Comparison of Near-infrared Versus Short-wave Autofluorescence Imaging in Monitoring Progression of Retinitis Pigmentosa. Am J Ophthalmol 194:120-125
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Shang, Enyuan; Zhang, Yiru; Shu, Chang et al. (2018) Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Sci Rep 8:15383
Shen, Megan Johnson; Prigerson, Holly G; Ratshikana-Moloko, Mpho et al. (2018) Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol :1-9
Apatoff, Mary Ben L; Sengillo, Jesse D; White, Eugenia C et al. (2018) Autologous stem cell therapy for inherited and acquired retinal disease. Regen Med 13:89-96
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439

Showing the most recent 10 out of 331 publications